Navigation Links
ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease
Date:8/19/2008

ate Scientist and Project Manager, via email at blevine@als.net or by phone at (617) 441-7200.

About the ALS Therapy Development Institute

The ALS Therapy Development Institute (ALS TDI) (http://www.als.net), based in Cambridge, Mass., operates the world's largest research and development program focused exclusively on ALS. At ALS TDI, a staff of over 30 scientists and research technicians work on behalf of ALS patients to discover and advance novel therapeutics for treating, and ultimately curing, ALS. The nonprofit biotechnology institute excels in identifying novel disease targets, discovering compounds that may act against these targets, and screening potential treatments for clinical development.

About Augie's Quest

Fitness pioneer Augie Nieto started Augie's Quest (http://www.augiesquest.org) in conjunction with MDA's ALS Division. Nieto is co-founder and former president of Life Fitness of Chicago, and chairman of Octane Fitness. He and his wife, Lynne, serve as co-chairpersons of MDA's ALS Division. Nieto received a diagnosis of ALS in March 2005.

About MDA

MDA (http://www.mda.org) is the world's largest provider of ALS services and funder of ALS research. Over the years, it has expended $230 million in this effort. It operated 225 clinics across the county, 38 of which are ALS-specific research and care centers.

Media Contacts: Robert Goldstein, ALS TDI, 617.441.7295, rgoldstein@als.net


'/>"/>
SOURCE ALS Therapy Development Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
8. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
9. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)...., Nov. 19 Amgen,(Nasda...mpany, a subsidiary of,Takeda Pharmaceutical Comp...ollment in the Phase 3 MONET1 trial evaluating mot...nd carboplatin for the first-line treatment of,ad... temporarily suspended,following a planned safety...
(Date:11/19/2008)...Nov. 19 Biotech scientists increas...logy research to better understand the effects of ...s, reports Genetic Engineering & Biotechnolog... figuring out a new compound,s mechanism of action... technique, according to the November 15 issue of ...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:...and drug development Company,and Sosei Group Cor...ding,international biopharmaceutical company, tod...ther pivotal pre-clinical efficacy data for NSL-04... therapy for neuropathic pain and has,successfull...
(Date:11/18/2008)... 18 Forty-two leading U...mber national forum to consider cutting-edge innov... national economy from outbreaks of dangerous zoon... , Among those innovations: , , , ...hen table that detects highly contagious and dange...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2International Aid Named as a MinistryWatch com Shining Light Christian Ministry 8404 1International Aid Named as a MinistryWatch com Shining Light Christian Ministry 8404 2IQS Donates Quality Management Software to Family Health International 8402 1IQS Donates Quality Management Software to Family Health International 8402 2IQS Donates Quality Management Software to Family Health International 8402 3Genome Technology Magazine Names Top Young Investigators of 2007 2246 1Genome Technology Magazine Names Top Young Investigators of 2007 2246 2Robin C Stracey Joins Cantimer Inc as President and CEO 2244 1Robin C Stracey Joins Cantimer Inc as President and CEO 2244 2
...novative technology has enabled more and more labo...ns office, the central laboratory is hardly threat... that medium and large labs are busier than ever b...old standard reliability and ability to handle ver...nd pivotal position in the clinical landscape. ,...
...rus (EBV), which causes infectious mononucleosis (...occurs worldwide, and most people become infected ...d States, as many as 95 percent of adults between ... developed countries, including the U.S., infectio... young adulthood, causing infectious mononucleosis...
Other Medicine Technology:When Volume Matters, Immunoassay Systems Deliver 2When Volume Matters, Immunoassay Systems Deliver 3Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 2Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 3
(Date:11/21/2008)...Nov. 21 The Providence S...ced that Craig A. Norris, the Company,s,Chief Ope...s Board of,Directors. Mr. Norris, appointment fi...n of Steven I. Geringer and returns the board to s...mittee of the Board. , Mr. Norris, age 41, ...
(Date:11/21/2008)...anzel proved effective against Lennox-Gastaut synd...) -- A new drug called Banzel (rufinamide) has bee...re form of epilepsy called Lennox-Gastaut syndrome...Friday. , The approval was based on results of ... ages 4 to 30. Compared to patients who took a pla...
(Date:11/21/2008)...a., Nov. 21 New researc...er a smokeless, spitless tobacco product aimed at ...ave found that RJ Reynolds, Camel Snus - touted as...contains surprisingly high levels of nicotine. , ...st other snuff products," said Bruce Adkins of the...
(Date:11/21/2008)... Nov. 21 U.S. News &...ity Assurance (NCQA) ranked BlueChoice(R) HealthPl... Best Health Plans(TM), published in U.S. News &am...respected annual ranking ranks the nation,s best h...sfaction and NCQA accreditation scores. NCQA and U...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2
...ore has announced that it will be shortly implemen...cted with bird flu can be immediately isolated. //...ergency vaccination program should the threat of b...nfecting facilities and restricted entry are alrea...
...d obesity rates are soaring as well.Studies say th...he world by the end of the decade and raise the ri...2010 the number of overweight and obese youngsters...would be 26 million. Over a million children will...
... urban Ontario and followed over two years, resear...nizations. //Dr. Astrid Guttmann, lead author of t...ciences (ICES) said that the overall visit rates t...t was later found that the mothers of the kids vis...
...ed of bird flu, Hong Kong banned the imports of li... The man is believed to have contracted the virus ...e bordering Hong Kong and one of the territory's m...d Thursday, nine days after being hospitalised aft...
Other Medicine News:Health News:Vaccination Schedules Rates among Canadian Kids Dip Low 2
For Tricuspid Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters for mapping in the atrium. The HALO XP 20-pole deflectable catheter is designed for simple placement and
...sense Webster is the source for a complete line of...d mapping - all with the quality, reliability and ... leader in catheter technology. All of our coronar...nstructed to help minimize the frustration and exc...
The reliable, easy-to-steer Bart EPXT catheter offers an exceptional blend of shaft stability and curve control for faster, more accurate mapping. Bard's exclusive point-of-tip actuation control supp
Sophisticated DecaPolar Catheters provide enhanced recording and mapping quality.
Medicine Products: